Moderna (MRNA) has had the highest return since June 9, 2026 by a US stock with a market cap of $50B+, returning 342.3%.
| ASSET | % RETURN |
|---|---|
Moderna (MRNA) | 342.31% |
Atlassian (TEAM) | 130.95% |
Natera (NTRA) | 95.95% |
Veeva Systems Inc Class A (VEEV) | 92.02% |
Marathon Petroleum (MPC) | 67.19% |
Crowdstrike (CRWD) | 61.91% |
Valero Energy (VLO) | 51.45% |
Phillips 66 (PSX) | 51.12% |
Thermo Fisher Scientific (TMO) | 48.98% |
Palo Alto Networks (PANW) | 48.7% |
Palantir Technologies (PLTR) | 45.93% |
Accenture (ACN) | 43.15% |
Snowflake (SNOW) | 42.22% |
Thomson Reuters Corporation Common Shares (TRI) | 40.71% |
ServiceNow (NOW) | 36.1% |
Agilent Technologies (A) | 35.64% |
Salesforce (CRM) | 35.47% |
Travelers Companies (TRV) | 32.97% |
SAP SE ADR (SAP) | 32.53% |
Takeda Pharmaceutical Co Ltd ADR (TAK) | 31.35% |
Becton Dickinson and (BDX) | 31.12% |
Amgen (AMGN) | 30.5% |
Regeneron Pharmaceuticals (REGN) | 30.45% |
Microsoft (MSFT) | 30.07% |
Equinor ASA ADR (EQNR) | 29.96% |